Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now ...

According to Nasdaq’s data, the U.S. saw 179 non-SPAC IPOs in 2024 – the most since 2021, and a 40% increase over 2023 (127). By value raised (ex SPACs), it was an even better year, with value raised ...

Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...

Underwriters have a 30-day option to purchase extra 1.13 million shares from present owners at IPO price. Beta Bionics will not profit monetarily from the sales of this secondary share. Under the ...

Formed in 2019, Sionna's most recent financing was a $182 million third round that closed last year, which followed a $111 ...

As a result, Renaissance expects a banner year for IPOs, with an estimated volume range of 155 to 195 IPOs in 2025 and $40 billion to $55 billion in new funding as the market "normalizes" in 2025. "A ...

Key Takeaways Smithfield Foods unveiled terms Tuesday for its planned initial public offering, with the largest U.S. pork ...

Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.

Nasdaq CEO Adena Friedman is optimistic that President Trump's administration will offer a chance to relook regulations in ...

Smithfield Foods is targeting a valuation of up to $10.73 billion in its New York flotation, the Farmland bacon maker said on ...

Skadden, Latham, Kirkland and Davis Polk—traditionally the strongest legal advisers for major U.S. listings by Chinese companies—acted on fewer than five of these IPOs last year, according to a ...

Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the ...